| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Elms Steve is a Director at ADMA Biologics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 8 sells.
Estimated insider holdings value: $17.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | ADMA Adma Biologics, Inc. | Director | Buy | 14,000 | $15.53 | $217,420.00 | +0.3% | - | - | |
| Jun 16, 2025 | ADMA Adma Biologics, Inc. | Director | Sale+OE | 425,621 | $20.74 | $8,829,333.47 | -15.1% | -25.0% | - | |
| Dec 23, 2024 | MRKR Marker Therapeutics, Inc. | Director | Buy | 11,085 | $3.20 | $35,472.00 | +3.5% | -62.6% | -60.5% | |
| Mar 19, 2024 | ADMA Adma Biologics, Inc. | Director | Sell | 461,716 | $6.07 | $2,803,741.19 | -9.0% | +68.7% | +233.0% | |
| Mar 15, 2024 | ADMA Adma Biologics, Inc. | Director | Sell | 1,038,284 | $6.11 | $6,339,417.88 | -10.8% | +80.0% | +207.7% | |
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | Director | Buy | 1,142,857 | $1.75 | $1,999,999.75 | +57.1% | +91.4% | -77.7% |